A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS

JA Vazquez, DJ Skiest, L Nieto… - Clinical infectious …, 2006 - academic.oup.com
Background. Oropharyngeal candidiasis is the most common opportunistic infection among
persons infected with human immunodeficiency virus (HIV). Use of some agents is …
被引用次数：224 相关文章
[PDF] archive.org

[PDF][PDF] A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS

JA Vazquez, DJ Skiest, L Nieto… - Clinical Infectious …, 2006 - scholar.archive.org
Background. Oropharyngeal candidiasis is the most common opportunistic infection among
persons infected with human immunodeficiency virus (HIV). Use of some agents is …

[引用][C] A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS

JA Vazquez, DJ Skiest, L Nieto, R Northland… - Clinical Infectious …, 2006 - cir.nii.ac.jp
A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the
Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS | CiNii Research CiNii 国立 …

A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS

JA Vazquez, DJ Skiest, L Nieto… - Clinical Infectious …, 2006 - augusta.elsevierpure.com
Background. Oropharyngeal candidiasis is the most common opportunistic infection among
persons infected with human immunodeficiency virus (HIV). Use of some agents is …

[引用][C] A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS …

JA VAZQUEZ, DJ SKIEST, L NIETO… - Clinical infectious …, 2006 - pascal-francis.inist.fr
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of
oropharyngeal candidiasis in subjects with HIV/AIDS. Commentary CNRS Inist Pascal-Francis …

A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS

JA Vazquez, DJ Skiest, L Nieto, R Northland… - Clinical Infectious …, 2006 - JSTOR
Background. Oropharyngeal candidiasis is the most common opportunistic infection among
persons infected with human immunodeficiency virus (HIV). Use of some agents is …

A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS

JA Vazquez, DJ Skiest, L Nieto, R Northland, I Sanne… - 2006 - pubmed.ncbi.nlm.nih.gov
Background Oropharyngeal candidiasis is the most common opportunistic infection among
persons infected with human immunodeficiency virus (HIV). Use of some agents is …

A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.

JA Vazquez, DJ Skiest, L Nieto… - … Diseases: an Official …, 2006 - europepmc.org
Background Oropharyngeal candidiasis is the most common opportunistic infection among
persons infected with human immunodeficiency virus (HIV). Use of some agents is …
[PDF] researchgate.net

[PDF][PDF] A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS

JA Vazquez, DJ Skiest, L Nieto… - Clinical Infectious …, 2006 - researchgate.net
Background. Oropharyngeal candidiasis is the most common opportunistic infection among
persons infected with human immunodeficiency virus (HIV). Use of some agents is …

A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.

JA Vazquez, DJ Skiest, L Nieto, R Northland, I Sanne… - 2006 - cabidigitallibrary.org
Background. Oropharyngeal candidiasis is the most common opportunistic infection among
persons infected with human immunodeficiency virus (HIV). Use of some agents is …